{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:05:48Z","timestamp":1776978348702,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>\n                    The prognosis for pediatric hematological malignancies has improved greatly, but infectious diseases, especially invasive fungal infection (IFI), are an important complication that may make it difficult to continue treatment. In this study, IFIs in the treatment of the initial diagnosis of acute lymphoblastic leukemia (ALL), excluding relapse and transplantation, were investigated retrospectively. The patients were 152 first-diagnosed ALL cases (85 males and 67 females) admitted to our hospital between April 2007 and December 2024. The median age of these patients was 6.8 years. The median leukocyte count was 10.2\u00d710\n                    <jats:sup>9<\/jats:sup>\n                    \/L and the cell surface markers of the blasts were B precursor in 124 cases, T in 20 cases, mature B in 3 cases, and mixed lineage in 5 cases. The diagnosis of IFI was based on EORTC\/MSG diagnostic criteria. Sixteen of the 152 patients (10.5%) were found to have IFIs; one was \u201cproven,\u201d 7 were \u201cprobable,\u201d and 8 were \u201cpossible.\u201d The median time of IFI onset from the start of ALL treatment was 41 days (\u22127 to 258\u00a0 d), with 56.3% of cases occurring at first onset of ALL or during induction therapy. Although 4 of 16 patients with IFIs died, IFI was the direct cause of death in 2 cases. Age 7.5 years or older was the only risk factor for IFI.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003191","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:00:15Z","timestamp":1774623615000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Fungal Infection in Patients With Initial Treatment of Pediatric Acute Lymphoblastic Leukemia: A Single-Center Study in Japan"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3937-0856","authenticated-orcid":false,"given":"Ryoji","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirozumi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjiro","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/pbc.21868","article-title":"Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis","volume":"52","author":"Kaya","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pbc.22750","article-title":"Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study","volume":"55","author":"Castagnola","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2009.08072.x","article-title":"Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant","volume":"149","author":"Hale","year":"2010","journal-title":"Br J Haematol"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal infections in pediatric oncology","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/MPH.0b013e3181864a80","article-title":"The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan","volume":"30","author":"Kobayashi","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/INF.0000000000002010","article-title":"Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan","volume":"37","author":"Kobayashi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"e31643","DOI":"10.1002\/pbc.31643","article-title":"Impact of invasive fungal diseases on treatment outcomes in pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: insights from a single-center study","volume":"72","author":"Murthy","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bjh.15798","article-title":"The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia\/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study","volume":"186","author":"O\u2019Reilly","year":"2019","journal-title":"Br J Haematol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"e27915","DOI":"10.1002\/pbc.27915","article-title":"Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003-2013","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41375-022-01768-x","article-title":"Invasive fungal diseases impact on outcome of childhood ALL-an analysis of the international trial AIEOP-BFM ALL 2009","volume":"37","author":"Lehrnbecher","year":"2023","journal-title":"Leukemia"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPH.0000000000000760","article-title":"Japan Association of Childhood Leukemia Study (JACLS), Japan. Long-term results of the risk-adapted treatment for childhood B-cell acute lymphoblastic leukemia: report from the Japan Association of Childhood Leukemia Study ALL-97 Trial","volume":"39","author":"Horibe","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41408-020-0287-4","article-title":"Risk-adjusted therapy for pediatric non-T-cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02","volume":"10","author":"Hasegawa","year":"2020","journal-title":"Blood Cancer J"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.24.00811","article-title":"JCCG ALL-B12: evaluation of intensified therapies with vincristine\/dexamethasone pulses and asparaginase and augmented high-dose methotrexate for pediatric B-ALL","volume":"43","author":"Kato","year":"2025","journal-title":"J Clin Oncol"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2352-3026(23)00072-8","article-title":"Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group","volume":"10","author":"Sato","year":"2023","journal-title":"Lancet Haematol"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cam4.383","article-title":"Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from Japanese Pediatric Leukemia\/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04","volume":"4","author":"Manabe","year":"2015","journal-title":"Cancer Med"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/leu.2014.172","article-title":"Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia","volume":"29","author":"Koh","year":"2015","journal-title":"Leukemia"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood.2019004741","article-title":"A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial","volume":"136","author":"Tomizawa","year":"2020","journal-title":"Blood"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/ejh.14148","article-title":"Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: a report from the JPLSG B-NHL14 trial","volume":"112","author":"Mori","year":"2024","journal-title":"Eur J Haematol"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"e28763","DOI":"10.1002\/pbc.28763","article-title":"Comparison of myelosuppression using the D-index between children and adolescents\/young adults with acute lymphoblastic leukemia during induction chemotherapy","volume":"68","author":"Matsushima","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ped.12031","article-title":"Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children","volume":"55","author":"Sano","year":"2013","journal-title":"Pediatr Int"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"e0160824","DOI":"10.1128\/aac.01608-24","article-title":"Comparison of two-hour drip infusion of meropenem versus piperacillin\/tazobactam for febrile neutropenia in pediatric patients","volume":"69","author":"Kobayashi","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.3390\/cancers14205022","article-title":"Infectious complications of targeted therapies in children with leukemias and lymphomas","volume":"14","author":"Kyriakidis","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:00:28Z","timestamp":1776974428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003191","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2025-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}